Lundbeck says Alzheimer's late-stage study fails
September 22, 2016 at 13:43 PM EDT
Sept 22 (Reuters) - Danish drugmaker H Lundbeck A/S said its late-stage study testing an experimental drug to treat mild to moderate Alzheimer's disease failed.